Investment Summary

Polaris Partners Invests In FOLX Health

On December 3, 2020, growth capital firm Polaris Partners invested in consumer products company FOLX Health

Investment Highlights
  • This is Polaris Partners’ 3rd transaction in the Consumer Products sector.
  • This is Polaris Partners’ 59th transaction in the United States.
  • This is Polaris Partners’ 16th transaction in Massachusetts.

Investment Summary
Date 2020-12-03
Target FOLX Health
Sector Consumer Products
Investor(s) Polaris Partners
Deal Type Venture

Target

FOLX Health

Boston, Massachusetts, United States
Folx Health is a digital health and wellness platform that delivers personalized, consumer grade, Queer-competent health care, centered on the LGBTQIA community. FOLX Health was founded in 2020 and is based in Boston, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Polaris Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.

DEAL STATS #
Overall 64 of 87
Sector (Consumer Products) 3 of 3
Type (Venture) 36 of 57
State (Massachusetts) 16 of 27
Country (United States) 59 of 78
Year (2020) 8 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 Noema

Basel, Switzerland

Noema is developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema was founded in 2019 and is based in Basel, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-27 Auron Therapeutics

Newton, Massachusetts, United States

Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. Auron Therapeutics is based in Newton, Massachusetts.

Buy -
Mergr

Product

Company

Legal